Mayra Ponce
Montreal, QC, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Metagenomics and culturomics reveal the dual role of the gut microbiome in the development of immune-related toxicities and the efficacy of immune checkpoint inhibitors in cancer.
Journal: Microbiome
Published: September 02, 2025
Fecal microbiota transplantation plus immunotherapy in non-small cell lung cancer and melanoma: the phase 2 FMT-LUMINate trial.
Journal: Nature medicine
Published: July 24, 2025
Diet-microbiome synergy underlies obesity-associated immunotherapy efficacy.
Journal: Nature
Published: June 21, 2024
The DAV132 colon-targeted adsorbent does not interfere with plasma concentrations of antibiotics but prevents antibiotic-related dysbiosis: a randomized phase I trial in healthy volunteers.
Journal: Nature communications
Published: June 05, 2024
Gut microbiome predicts gastrointestinal toxicity outcomes from chemoradiation therapy in patients with head and neck squamous cell carcinoma.
Journal: Oral oncology
Published: June 24, 2023
Helicobacter pylori serology is associated with worse overall survival in patients with melanoma treated with immune checkpoint inhibitors.
Journal: Oncoimmunology
Published: July 14, 2022
Showing 1-8 of 8
Last Updated: 09/26/2026